Sivik Global Healthcare’s Express Scripts Holding Company ESRX Stock Holding History

Sivik Global Healthcare’s Portfolio ESRX Stock Details ESRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-50,000	Closed	-$3.86M	–	74
2018 Q2	$3.86M	Buy	+50,000	New	+$3.75M	1.48%	35
2018 Q1	–	Sell	-35,000	Closed	-$2.61M	–	74
2017 Q4	$2.61M	Buy	35,000 +5,000	+17%	+$320K	0.97%	50
2017 Q3	$1.9M	Buy	+30,000	New	+$1.86M	0.65%	56
2016 Q3	–	Sell	-55,000	Closed	-$4.11M	–	66
2016 Q2	$4.17M	Buy	+55,000	New	+$4.04M	2.07%	19
2015 Q2	–	Sell	-25,000	Closed	-$2.17M	–	80
2015 Q1	$2.17M	Sell	25,000 -21,666	-46%	-$1.82M	0.74%	60
2014 Q4	$3.95M	Buy	+46,666	New	+$3.65M	1.6%	25
2014 Q1	–	Sell	-44,700	Closed	-$3.14M	–	75
2013 Q4	$3.14M	Buy	+44,700	New	+$2.92M	2.23%	16

Other funds holding ESRX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Sivik Global Healthcare's ESRX Position: Q3 2018 in Review

Sivik Global Healthcare sold out of Express Scripts Holding Company (ESRX) in Q3 2018, closing a stake of 50,000 shares — an estimated $3.86M sold.

Sivik Global Healthcare first reported a position in ESRX in Q4 2013 and held it in 7 quarters. The position peaked at $4.17M in Q2 2016. 1,130 funds tracked by Wall St. Rank hold ESRX as of Q3 2018.

Sivik Global Healthcare reported no remaining Express Scripts Holding Company position as of Q3 2018 after selling out during the quarter.
Sivik Global Healthcare sold 50,000 Express Scripts Holding Company shares in Q3 2018, an estimated $3.86M.
Sivik Global Healthcare first reported a position in Express Scripts Holding Company in Q4 2013 and held it in 7 quarters.
Sivik Global Healthcare's Express Scripts Holding Company position peaked at $4.17M in Q2 2016.
1,130 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q3 2018.

Based on Sivik Global Healthcare's 13F filing for Q3 2018, filed 13 Nov 2018.